Table search / Research Frontiers Incorporated / "Research and Development"

4 results

Newest first Best match first

2024 Q3

	2024		2023		2024		2023
	Nine months ended September 30,				Three months ended September 30,
	2024		2023		2024		2023

Fee income	$	1,157,380	$	597,362	$	354,408	$	164,146

Operating expenses		1,565,152		1,695,129		454,866		542,635
Research and development		409,817		430,150		131,246		135,319
Total expenses		1,974,969		2,125,279		586,112		677,954

Operating loss		(817,589)		(1,527,917)		(231,704)		(513,808)

Net investment income		78,995		99,463		29,736		41,642
Other income		35,152		-		35,152		-

Net loss	$	(703,442)	$	(1,428,454)	$	(166,816)	$	(472,166)

Basic and diluted net loss per common share	$	(0.02)	$	(0.04)	$	(0.00)	$	(0.01)

Weighted average number of common shares outstanding		33,515,327		33,435,074		33,517,787		33,509,287

7 Nov 24

4:01pm

10-Q

2024 Q2

REFR Research Frontiers Incorporated

Quarterly report

	2024		2023		2024		2023
	Six months ended June 30,				Three months ended June 30,
	2024		2023		2024		2023

Fee income	$	802,972	$	433,215	$	489,594	$	185,040

Operating expenses		1,110,285		1,152,493		476,898		564,694
Research and development		278,571		294,832		128,830		145,610
Total expenses		1,388,856		1,447,325		605,728		710,304

Operating loss		(585,884)		(1,014,110)		(116,134)		(525,264)

Net investment income		49,258		57,822		22,112		31,614

Net loss	$	(536,626)	$	(956,288)	$	(94,022)	$	(493,650)

Basic and diluted net loss per common share	$	(0.02)	$	(0.03)	$	(0.00)	$	(0.01)

Weighted average number of common shares outstanding		33,514,097		33,397,968		33,517,787		33,509,287

1 Aug 24

4:01pm

10-Q

2024 Q1

REFR Research Frontiers Incorporated

Quarterly report

	2024		2023
	Three months ended March 31,
	2024		2023

Fee income	$	313,378	$	248,175

Operating expenses		633,387		587,799
Research and development		149,741		149,222
Total expenses		783,128		737,021

Operating loss		(469,750)		(488,846)

Net investment income		27,146		26,208

Net loss	$	(442,604)	$	(462,638)

Basic and diluted net loss per common share	$	(0.01)	$	(0.01)

Weighted average number of common shares outstanding		33,510,408		33,286,648

9 May 24

4:01pm

10-K

2023 FY

REFR Research Frontiers Incorporated

Annual report

	2023		2022

Fee income	$	909,598	$	539,686

Operating expenses		2,359,634		2,555,689
Research and development		583,266		609,127
Total expenses		2,942,900		3,164,816

Operating loss		(2,033,302)		(2,625,130)

Net investment income (loss)		124,938		(44,219)

Net loss	$	(1,908,364)	$	(2,669,349)

Basic and diluted net loss per common share	$	(0.06)	$	(0.08)

Weighted average number of common shares outstanding		33,453,627		32,070,233

7 Mar 24

4:01pm

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.

Table search / Research Frontiers Incorporated / "Research and Development"

4 results

Top filers

Top filing types

Recent filing years